“It’s a really, really big problem, not only for individual patients, but also for society.”
Penicillin, one of the scientific marvels of the 20th century, is currently losing a lot of battles it once won against bacterial infections. But scientists at the University of South Carolina have just reported a new approach to restoring its combat effectiveness, even against so-called “superbugs.”
Bacteria have been chipping away at the power of the penicillin family of drugs since their first wide-scale use as antibiotics in the 1940s. For example, the staph infection, brought about by the bacterium Staphylococcus aureus, was once readily treated with penicillin and its molecular cousins.
But that bug has changed. In the 1960s, a new strain arrived, termed MRSA for methicillin- (or sometimes multidrug-) resistant S. aureus. It has become a serious public health problem because the earliest deployed antibiotics are often useless against the new strain, and its prevalence has only increased since it was first observed. MRSA (pronounced mer-suh) is sometimes called a superbug because of the difficulty physicians have in treating infected patients.
The S. aureus microbe has evolved the MRSA strain by developing a variety of defenses against antibiotics to which they’ve been exposed. One of those defenses effectively neutralizes penicillin’s greatest strength.
That strength is its molecular core, a cyclic four-membered amide ring termed a beta-lactam. It is a common structural element of the penicillins, their synthetic and semi-synthetic derivatives, and other related molecules that constitute the broad family of drugs called the beta-lactam antibiotics. Just a few examples (of dozens) include amoxicillin, ampicillin and cefazolin.
The beta-lactam structure in a molecule is something that many bacteria don’t like at all. It greatly hinders their ability to reproduce by cell division, and so chemists have for years spent time making molecules that all contain the beta-lactam structural motif, but differ in the surrounding molecular “shrubbery.” Physicians heavily use the many versions of beta-lactam antibiotics to fight bacterial infections, and many have been retired because they’re no longer effective against the defenses bacteria have evolved in response.
One of the most effective bacterial defenses is an enzyme called beta-lactamase, which chews up the beta-lactam structure. Some bacteria, such as MRSA, have developed the ability to biosynthesize and release beta-lactamase when needed. It’s a devastating defense because it’s so general, targeting the common structural motif in all of the many beta-lactam antibiotics.
But that also creates the opportunity for a general approach to solving the problem, which is what Carolina’s Chuanbing Tang and colleagues just reported in the Journal of the American Chemical Society.
“Instead of developing new antibiotics, here we ask the question, ‘can we recycle the old antibiotics?’ ” he said. “With traditional antibiotics like penicillin G, amoxicillin, ampicillin and so on, can we give them new life?”
The approach pairs the drug with a protective polymer developed in Tang’s chemistry laboratory. In lab tests, graduate student Jiuyang Zhang prepared a cobaltocenium metallopolymer that greatly slowed the destructiveness of beta-lactamase on a model beta-lactam molecule (nitrocefin).
The interdisciplinary team, which included Mitzi Nagarkatti and Alan Decho, from the university’s School of Medicine and Arnold School of Public Health, respectively, also showed that the antimicrobial effectiveness of the four beta-lactams studied in detail was enhanced by the polymer. The enhancement was modest against two strains, but very pronounced with the hospital-associated strain of MRSA (HA-MRSA).
The metallopolymer by itself even demonstrated antimicrobial properties, lysing bacterial cells while leaving human red blood cells unaffected. By a variety of measures, the polymer was found to be nontoxic to human cells in laboratory tests.
The project is still far from clinical use, but Tang knows moving forward is imperative.
“In the United States every year, around 100,000 patients die of bacteria-induced infections,” Tang said. “And the problem is increasing because bacteria are building resistance.
“It’s a really, really big problem, not only for individual patients, but also for society.”
The Latest on: Superbug
[google_news title=”” keyword=”Superbug” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Superbug
- Researchers Invent AI Model to Design New Superbug-Fighting Antibioticson March 25, 2024 at 12:35 pm
Novel AI model, SyntheMol, generates billions of inexpensive antibiotic molecules targeting drug-resistant bacteria ...
- New AI model to design superbug-fighting antibioticson March 25, 2024 at 4:00 am
Researchers from McMaster and Stanford Universities have developed a new generative artificial intelligence model which can design billions of new antibiotic molecules.
- AI Model Can Design Millions of New Superbug-Fighting Antibioticson March 25, 2024 at 3:28 am
The spread of drug-resistant bacteria has created an urgent need for new antibiotics. Researchers report that they have developed a new generative AI model that can design new antibiotics to stop the ...
- Researchers invent artificial intelligence model to design new superbug-fighting antibioticson March 23, 2024 at 3:20 pm
Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence model which can design billions of new antibiotic molecules that are inexpensive and ...
- Everywhere in Cambridgeshire where Victorian superbug has been foundon March 22, 2024 at 8:00 pm
Nearly a dozen suspected cases of a Victorian disease responsible for more deaths worldwide than almost any other bug have been diagnosed in Cambridgeshire in the first three months of 2024.
- Terrifying map shows spread of deadly Victorian superbug as it surges across UKon March 19, 2024 at 3:58 am
While the data from 2022 was below pre-pandemic figures, the UKHSA shared infections are now back on rise. The figures from 2023 show there were 4,850 cases of TB in England last year - an 11 percent ...
- Deadly Victorian superbug mapped as experts say UK infection 'now above pre-pandemic levels'on March 18, 2024 at 5:00 pm
A Victorian disease which can spread by close contact is on the rise. Almost 1,000 suspected cases of Tuberculosis or TB have been diagnosed across England and Wales so far this year. Infections ...
- 'Healthy' woman, 29, dies days after catching superbug that 'ate holes in her lungs'on March 12, 2024 at 10:26 am
Ashley Timbery, 29, seemed perfectly healthy until she fell down outside and was rushed to hospital in Sydney, Australia, where doctors found she had a superbug ...
- 'Superbug' cases rising in Las Vegas Valley, here's what is being done:on March 11, 2024 at 5:00 pm
The Superbug, known for its resistance to anti-fungal medications has been found in elevated levels in our city's wastewater. Back in January, the Nevada Department of Health and Human Services ...
- A superbug almost took my life. Here’s how we can fight them | Opinionon February 26, 2024 at 1:32 am
The world urgently needs new antibiotics. I know this first-hand because I nearly died from a bacterial infection that overpowered all but the final antibiotic doctors had available to treat it ...
via Bing News